Target intelligence / Profile preview

novel transcript, antisense to MPP4 and TMEM237 (ENSG00000287133)

Target: ENSG00000287133
Molecular classification: Other (lncRNA)

Overview

ENSG00000287133 is an uncharacterized long non-coding RNA gene ("novel transcript, antisense to MPP4 and TMEM237"), so named because its sequence runs antisense to the MPP4 and TMEM237 loci. It does not encode a protein, and as of current knowledge, no biological function, disease association, or therapeutic relevance has been reported in biomedical sources[3]. There are no aliases, drug interactions, or disease biomarker uses known for this transcript. It should not be classified as a canonical druggable target.

Mechanism of action

None applicable

Biological functions

Unknown

Beyond the preview

Go deeper on novel transcript, antisense to MPP4 and TMEM237 (ENSG00000287133).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to MPP4 and TMEM237 (ENSG00000287133).

Explore the full profile